Yuigi Yuminaga retweetledi

NEW Research—Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic #renalcellcarcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial hubs.ly/H0hQjTK0

English



















